Centaurus Financial’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$170K Sell
6,177
-35
-0.6% -$963 0.01% 776
2025
Q1
$176K Sell
6,212
-75
-1% -$2.13K 0.01% 716
2024
Q4
$261K Sell
6,287
-13
-0.2% -$540 0.02% 592
2024
Q3
$421K Sell
6,300
-35
-0.6% -$2.34K 0.03% 447
2024
Q2
$752K Sell
6,335
-608
-9% -$72.2K 0.05% 295
2024
Q1
$740K Sell
6,943
-140
-2% -$14.9K 0.05% 295
2023
Q4
$704K Buy
7,083
+214
+3% +$21.3K 0.05% 299
2023
Q3
$709K Sell
6,869
-68
-1% -$7.02K 0.06% 293
2023
Q2
$843K Sell
6,937
-1,555
-18% -$189K 0.07% 266
2023
Q1
$1.3M Buy
8,492
+35
+0.4% +$5.37K 0.1% 219
2022
Q4
$1.52M Sell
8,457
-403
-5% -$72.4K 0.14% 174
2022
Q3
$1.05M Sell
8,860
-110
-1% -$13K 0.1% 231
2022
Q2
$1.28M Sell
8,970
-374
-4% -$53.4K 0.13% 195
2022
Q1
$1.61M Buy
9,344
+39
+0.4% +$6.72K 0.13% 193
2021
Q4
$2.36M Sell
9,305
-606
-6% -$154K 0.18% 151
2021
Q3
$3.81M Sell
9,911
-3,445
-26% -$1.33M 0.32% 72
2021
Q2
$3.14M Buy
13,356
+6,918
+107% +$1.63M 0.26% 92
2021
Q1
$843K Buy
6,438
+1,198
+23% +$157K 0.08% 265
2020
Q4
$547K Sell
5,240
-3,923
-43% -$410K 0.06% 338
2020
Q3
$648K Buy
9,163
+537
+6% +$38K 0.09% 238
2020
Q2
$554K Buy
8,626
+5,126
+146% +$329K 0.08% 264
2020
Q1
$105K Buy
+3,500
New +$105K 0.02% 479